Conventional exercise group: All participants will receive a standardized electrotherapy program in a clinical setting, consisting of TENS (100 Hz, 30 minutes), ultrasound (1.5 W/cm², 8 minutes), and a 15-minute cold-pack application, delivered three times per week for four weeks. In addition to electrotherapy, participants in the conventional exercise group will perform a physiotherapist-guided exercise program aimed at improving shoulder flexion, abduction, internal and external rotation through stretching and range-of-motion exercises. The program will include Codman exercises, wand exercises, finger-ladder activities, and condition-appropriate strengthening exercises, progressed according to each participant's pain level and tolerance.
IASTM group: Participants in the IASTM group will receive Instrument-Assisted Soft Tissue Mobilization in addition to the conventional treatment program, three days per week for four weeks, for a total of 12 sessions. The IASTM technique will be applied to the subscapularis, anterior deltoid, biceps brachii, upper trapezius, supraspinatus, infraspinatus, teres major, teres minor, and posterior deltoid muscles.
For each muscle group, the treatment will be administered for 20 seconds in a parallel direction and 20 seconds in a perpendicular direction, using sweep and brush techniques at an angle of approximately 45 degrees.
Study summary
The aim of this study will be to investigate the effects of Instrument-Assisted Soft Tissue Mobilization (IASTM), applied in addition to a conventional exercise program, on pain, range of motion, proprioception, functionality, and quality of life in individuals with Subacromial Impingement Syndrome (SIS).
Eligibility
Sex
ALL
Min age
40 Years
Max age
60 Years
Healthy volunteers
Accepted
Inclusion Criteria:
* Individuals diagnosed with SIS by MRI
* Men and women between 40 and 60 years of age
* Individuals with symptoms persisting for at least one month
* Individuals with a minimum of 60° of shoulder flexion and abduction range of motion
Exclusion Criteria:
* Individuals with a history of surgery on the affected arm
* Individuals with an open wound on the arm
* Individuals with an active infection
* Individuals with inflammatory joint disease
* Individuals with malignant or benign tumors were excluded from the study.
Primary outcome measure(s)
Visual Analog Scale — From enrollment to the end of treatment at 4 weeks The Visual Analog Scale (VAS) is a tool used to measure pain intensity as a single-dimensional construct across different adult populations. It typically consists of a horizontal or vertical line measuring 10 cm in length. On this scale, a score of 0 indicates no pain, while a score of 10 represents the worst pain imaginable.
Range of motion — From enrollment to the end of treatment at 4 weeks Shoulder flexion, abduction, internal rotation, and external rotation range of motion will be assessed using a universal goniometer while the patient is positioned in supine and performs the movements actively.
The Disabilities of the Arm, Shoulder and Hand (DASH) — From enrollment to the end of treatment at 4 weeks The Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire is a scale that evaluates functional status and capability following injuries or disorders affecting the upper extremity. The DASH consists of 30 items. These items assess difficulties encountered during specific tasks, as well as pain, numbness, stiffness, weakness, sleep problems, self-confidence, and participation in social activities. Scores range from 0 to 100, with higher scores indicating greater impairment in upper extremity function.
Trial sites (1)
Facility
City
Region
Status
Istanbul Medipol University
Istanbul
Turkey (Türkiye)
Recruiting
More Istanbul Medipol University Hospital trials in Turkey
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.